InQpharm Group   Report issue

For profit Phase 3 Phase 4
Founded: Kuala Lumpur Malaysia (2004)
Status: No NME R&D (2004)

Organization Overview

First Clinical Trial
2011
NCT01423617
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

InQpharm Group

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Body Weight (Phase 4)

Common Cold (Phase 3)

Communicable Diseases (Phase 3)

Infections (Phase 3)

Irritable Bowel Syndrome (Phase 3)

Overweight (Phase 4)

Respiratory Tract Infections (Phase 3)

Syndrome (Phase 3)

Weight Loss (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 18
  • # of Trial APIs: 16